IP Library Granted Patent US 7,122,304
Granted Patent B2
US 7,122,304 · App. 09/725,897 · Granted Oct 17, 2006

Methods for the storage and synthesis of nucleic acids using a solid support

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,122,304
App. No.
09/725,897
Granted
Oct 17, 2006
Kind
B2
Abstract

The invention relates to storage of nucleic acid (particularly mRNA) on a solid support and to using such nucleic acid in nucleic acid synthesis or amplification reactions. In a preferred aspect, the invention provides synthesis of cDNA and cDNA libraries.

Claims (41)

1. A method of producing one or more cDNA molecules comprising:

(a) contacting a sample comprising a cell or a virus with a solid medium, wherein:

(i) the sample comprises mRNA and genomic DNA;

(ii) the mRNA comprises an mRNA-template of interest; and

(iii) wherein the solid medium comprises:

a matrix; and

a composition for inhibiting degradation of the mRNA template, wherein:

the composition comprises a detergent or surfactant; and

the composition is sorbed to the matrix then dried prior to contact with the sample;

(b) sorbing at least a portion of the mRNA template to the solid medium;

(c) eluting the mRNA from the solid medium while retaining the genomic DNA; and

(d) contacting the mRNA with one or more reverse transcriptases under conditions sufficient to synthesize one or more cDNA molecules complementary to all or a portion of the mRNA template of interest.

2. The method of claim 1 , wherein the cDNA is a cDNA library.

3. The method of claim 1 , wherein the cDNA is double-stranded.

4. The method of claim 1 , further comprising:

(e) amplifying the cDNA.

5. The method of claim 4 , wherein the amplifying step comprises contacting at least one cDNA strand with a polymerase under conditions to synthesize one or more cDNA molecules complementary to all or a portion of the template.

6. The method of claim 4 , wherein the amplifying step comprises a polymerase chain reaction (PCR).

7. The method of claim 1 , wherein the detergent or surfactant of the composition is an anionic detergent or surfactant and wherein the composition further comprises:

(a) a base; and

(b) a chelating agent.

8. The method of claim 7 , wherein the composition further comprises uric acid or a urate salt.

9. The method of claim 7 , wherein:

(a) the anionic detergent or surfactant comprises sodium dodecyl sulfate (SDS);

(b) the base comprises Tris or tris-hydroxymethyl methane; and

(c) the chelating agent comprises ethylene diamine tetra-acetic acid (EDTA).

10. The method of claim 1 , wherein the matrix comprises a cellulose-based matrix or paper, or a micromesh of synthetic plastic material.

11. The method of claim 1 , wherein the matrix is selected from the group consisting of nitrocellulose, cellulose, diazocellulose, carboxymethylcellulose, hydrophilic polymers, polytetra-fluoro-ethylene, fiberglass, porous ceramics, polystyrene, polyvinylchloride, polypropylene, polyethylene, dextran, agarose, agar, starch, and nylon.

12. The method of claim 1 , wherein the sample comprises a eukaryotic cell.

13. The method of claim 1 , wherein the eluting step further comprises contacting the solid medium comprising the mRNA with an elution buffer, wherein the elution buffer comprises:

(a) a base;

(b) a chelating agent;

(c) dithiothreitol; and

(d) a ribonuclease inhibitor.

14. The method of claim 13 , wherein the elution buffer further comprises:

(e) glycogen.

15. The method of claim 13 , wherein:

(a) the base comprises Tris or tris-hydroxymethyl methane; and

(b) the chelating agent comprises ethylene diamine tetra-acetic acid (EDTA).

16. The method of claim 13 , wherein the eluting step further comprises incubating the solid medium comprising the mRNA with the elution buffer at a temperature at or below 4° C.

17. The method of claim 13 , wherein the eluting step further comprises vortexing the solid medium comprising the mRNA with the elution buffer.

Assignments (2)
CHANGE OF NAME Recorded Aug 31, 2020
From: GE HEALTHCARE BIO-SCIENCES CORP.
To: GLOBAL LIFE SCIENCES SOLUTIONS USA LLC
Reel/Frame 053648/0854 →
MERGER Recorded Aug 4, 2011
From: WHATMAN, INC.
To: GE HEALTHCARE BIO-SCIENCES CORP.
Reel/Frame 026700/0634 →